Swiss pharmaceuticals giant Novartis announced over the weekend it would dish out $9.7 billion (8.8 billion euros) to acquire US firm Medicines Company, in a move aimed at boosting its cardiovascular treatment portfolio.
Nov 25, 2019
0
2
Targeting apolipoprotein B (APOB) gene has not been tested in clinical trials for cardiovascular outcomes because of risk of fatty liver disease, but naturally-occurring mutation suggests it may be effective.
May 13, 2019
0
6
Heart patients who can't tolerate the side effects of cholesterol-lowering drugs may have a new option, according to a new study by researchers from the Intermountain Heart Institute at Intermountain Medical Center in Salt ...
Mar 11, 2013
0
0
Furring of the arteries, atherosclerosis, is a leading cause of death across the world. Atherosclerosis leads to peripheral arterial disease, coronary heart disease, stroke and heart attacks. However, atherosclerosis is a ...
Jan 13, 2012
1
0
There is no evidence that adding a new cholesterol-lowering drug to treatment with a statin causes memory loss or other problems with cognition or thinking, according to findings from the EBBINGHAUS study, the largest, most ...
Mar 20, 2017
0
6
Previous research has shown the benefit of statins for reducing high cholesterol and heart disease risk amongst different patient populations. However, until now there has been no conclusive evidence from trials for current ...
Sep 6, 2017
0
12
The amount of remnant particle cholesterol in the blood, the so-called ugly cholesterol, is much higher than previously believed. This is shown in new research from the University of Copenhagen and Copenhagen University Hospital. ...
Aug 1, 2019
0
32
Substituting meat with plant-based meat alternatives lowers "bad" cholesterol, according to new research from the University of Warwick.
Mar 8, 2023
0
45
A new study is the first to show a food-based approach using clinically-proven diet interventions to lower cholesterol levels, such as Step One Foods, provides significant healthcare cost savings.
Aug 13, 2020
0
2
High levels of low-density lipoprotein (LDL) cholesterol in mid-life are associated with an increased risk of developing dementia and Alzheimer's over a decade later, according to a study published in The Lancet Healthy Longevity.
Jul 27, 2021
0
266
